ATG5 and head and neck squamous cell carcinoma: Furthermore, ATG5 expression was significantly positively correlated with G2M checkpoints in HNSCC (p < 0.001, Spearman coefficient = 0.41) and ATG5 high expression HNSCC patients had lower IC50 of G2M checkpoint inhibitors by predicted.